RELATED CONTENT
News | Artificial Intelligence
September 27, 2021 — Zebra Medical Vision, the deep-learning medical imaging analytics company, announces its eighth U.S ...
September 27, 2021 
News | X-Ray
August 11, 2021 — Nano-X Imaging Ltd, an innovative medical imaging company, announced entry into two agreements ...
August 11, 2021 
News | Artificial Intelligence
August 11, 2020 — Building on its commitment to providing customers with artificial intelligence (AI) solutions that can ...
August 11, 2020 
News | Breast Imaging
July 26, 2020 — Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo ...
July 27, 2020 
News | Artificial Intelligence
October 31, 2019 — Zebra Medical Vision, a deep learning medical imaging analytics company, announced this week a ...
October 31, 2019 
Technology | Artificial Intelligence
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for the company's HealthICH product. The new clearance covers an artificial intelligence (AI) alert for intracranial hemorrhage (ICH), based on head computed tomography (CT) scans.
June 19, 2019 
Technology | Artificial Intelligence
Zebra Medical Vision has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthPNX, an artificial intelligence (AI) alert for pneumothorax (PNX) based on chest X-rays.
May 13, 2019 
News | Artificial Intelligence
Zebra Medical Vision and Clalit Health Services announced the completion of two research projects that allow early identification of patients with bone and cardiovascular disease. Using existing computed tomography (CT) data, Zebra-Med’s algorithms allow Clalit to identify patients at risk of osteoporotic fractures and cardiac events. Both research projects were independently validated by the Clalit Research Institute and will be presented for the first time during the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago.
November 27, 2018 
Technology | Computed Tomography (CT)
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary Calcium Scoring algorithm. The algorithm, capable of automatically calculating a patient’s Agatston equivalent coronary calcium score from an electrocardiogram (ECG)-gated computed tomography (CT) scan, provides physicians with important data used in the assessment of the risk for coronary artery disease.
July 12, 2018 
News | Artificial Intelligence
June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future ar ...
June 08, 2018 